Oscar Health Second Quarter 2025 Earnings: Revenues Disappoint\n\nOscar Health (NYSE:OSCR) Second Quarter 2025 Results\n\nKey Financial Results\nRevenue: US$2.86b (up 29% from 2Q 2024). Net loss: US$228.4m (down from US$56.2m profit in 2Q 2024). US$0.89 loss per share (down from US$0.23 profit in 2Q 2024).\n\nRevenue missed analyst estimates by 1.9%. Earnings per share (EPS) was mostly in line with analyst estimates.\n\nLooking ahead, revenue is forecast to grow 5.0% p.a. on average during the next 3 years, compared to a 5.5% growth forecast for the Insurance industry in the US.\n\nThe company's shares are up 12% from a week ago.\n\nRisk Analysis\nDon't forget that there may still be risks. For instance, we've identified 2 warning signs for Oscar Health that you should be aware of.\n\nAbout NYSE:OSCR\nOscar Health operates as a healthcare technology company in the United States.\n\nSimilar Companies\nNYSE:CVS - CVS Health\nNYSE:DOCS - Doximity\n\nMarket Insights\n🤖 The Bull and Bear Thesis on AI’s Decade of Disruption\n💥 How Agentic AI Could Change Every Industry\nWho Will Win In The Age Of Agentic AI\n\nCommunity Narratives\nA Quality Compounder Marked Down on Overblown Fears\nFair Value US$120.72 | 57.7% undervalued\nWhy Now is the Time to buy ASML\nFair Value US$1.00k | 28.0% undervalued\nWyndham Continues Global Expansion with 19% Ancillary Revenue Growth\nFair Value US$105.80 | 20.6% undervalued

Oscar Health Second Quarter 2025 Earnings: Revenues Disappoint

Oscar Health reported its second quarter 2025 financial results, showing a 29% increase in revenue to $2.86 billion, which slightly missed analyst expectations by 1.9%. The company recorded a net loss of $228.4 million, down from a $56.2 million profit in the same period of 2024, translating to a loss of $0.89 per share compared to a $0.23 profit previously. Despite the revenue shortfall, earnings per share were in line with estimates. The company forecasts average annual revenue growth of 5.0% over the next three years, slightly below the U.S. insurance industry's projected 5.5% growth. Shares of Oscar Health rose 12% from the previous week. The article also highlights two warning signs related to the company's risk profile and references similar companies in the healthcare technology space, including CVS Health and Doximity.